Vortioxetine
Other Antidepressants
Sold as Brintellix · TRINTELLIX
- Drug class
- Other Antidepressants
- Availability
- See label
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 90
Overview
Vortioxetine is an active pharmaceutical ingredient in the Other Antidepressants group (N06AX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 81 | May 29, 2026 |
| CA Canada | Health Canada | 8 | April 15, 2025 |
| EU European Union | EMA | 1 | January 19, 2026 |
GBUnited Kingdom· MHRA
81 products
Uses
Vortioxetine is indicated for the treatment of major depressive episodes in adults.
How to take
CACanada· Health Canada
8 products
Uses
APO-VORTIOXETINE (vortioxetine tablets) is indicated for: • the treatment of major depressive disorder (MDD) in adults. 1 Clinical Trials by Indication, Study Results). 1 Clinical Trials by Indication, Study Results). Physicians who elect to use APO-VORTIOXETINE for extended periods should periodically re- evaluate the usefulness of the drug for individual patients.
1 Clinical Trial Adverse Reactions – Pediatrics). 1 Clinical Trials by Indication, Study Results).
How to take
EUEuropean Union· EMA
1 product
Uses
Brintellix is indicated for the treatment of major depressive episodes in adults.
How to take
Drug interactions
Known interactions involving Vortioxetine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 298. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL494450260 · revised May 29, 2026
- [2]Health Canada (DPD) · 02552744 · revised April 15, 2025
- [3]European Medicines Agency · EMEA/H/C/002717 · revised January 19, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.